Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT studyAndrew J. Burger, Uri Elkayam, Darlene P. Horton et al.|American Heart Journal|2002Cited by 323
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failureGuillermo Torre‐Amione, Isaac Kobrin, Maurizio Rainisio et al.|Journal of the American College of Cardiology|2003Cited by 119
The Hemodynamic and Neurohormonal Effects of Low Doses of Tezosentan (An Endothelin A/B Receptor Antagonist) in Patients with Acute Heart FailureGad Cotter, Guillermo Torre‐Amione, Edo Kaluski et al.|European Journal of Heart Failure|2004Cited by 58
Role of Endothelial and Mesenchymal Cell Transitions in Heart Failure and Recovery ThereafterGuangyu Wang, Arvind Bhimaraj, Ana Sofia Cruz et al.|Frontiers in Genetics|2021Cited by 14
Previous Cardiovascular Injury is a Prerequisite for Immune Checkpoint Inhibitor-Associated Lethal Myocarditis in MiceNéstor Rubio‐Infante, Guillermo Torre‐Amione|ESC Heart Failure|2023Cited by 7